肺动脉高压的目标导向治疗：源于新近指南的意见.pptVIP

PAH诊断 专家意见; 抗凝(IPAH, E/A; APAH, E/B) 急性血管反应实验 (IPAH, E/A, APAH, E/C) 应答 CCB (A) NYHA I/II 继续 FC II ERA/PDE5I (A) Preliminary 4th World Symposium PAH Dana Point, CA Feb 11-14, 2008 Diagnosis PAH 专家意见; 抗凝(IPAH, E/A; APAH, E/B) 急性血管反应实验 (IPAH, E/A, APAH, E/C) 应答 CCB (A) NYHA I/II 继续 FC II FC III FC IV ERA/PDE5I (A) ERA/PDE5I (A) Inh Iloprost (A) IV Epoprostenol (A) SC Treprostinil (B) IV Iloprost (C) IV Treprostinil (C) Beraprost (C) IV Epoprostenol (A) SC Treprostinil (B) Inh Iloprost (B) ERA/PDE5I (B) IV Iloprost (C) IV Treprostinil (C) Preliminary 4th World Symposium PAH Dana Point, CA Feb 1